Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2015

01-10-2015 | Original Article

Analysis of Familial Tendencies in Transferrin Saturation in a Korean Population

Authors: Sung-Hee Oh, Tae-Dong Jeong, Woochang Lee, Sail Chun, Won-Ki Min

Published in: Digestive Diseases and Sciences | Issue 10/2015

Login to get access

Abstract

Background

Despite the high transferrin saturation (TS) level in Koreans, the p.Cys282Tyr and p.His63Asp mutations are markedly less frequent than in Caucasians. We aimed to determine TS levels and their familial tendencies in a Korean population using nationwide data from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-1 2010).

Methods

A total of 4904 subjects without a history of hepatitis B and C virus infection, or liver cirrhosis, and who were negative for anemia and hepatitis B antigen were enrolled. A familial tendency analysis was performed in 260 families. Parents were grouped into four quartiles based on their TS levels. Offspring were categorized according to the mean parental TS four quartile scores (1.0, 1.5, 2.0, 2.5, 3.0, 3.5, and 4.0). A familial tendency was evaluated by comparing the mean TS of offspring in seven parental groups.

Results

The mean TS was 39.3 ± 15.6 % for Korean males and 33.2 ± 12.9 % for Korean females, and both were significantly higher than those of Caucasians reported in the HEIRS study (30.6 ± 11.0 % for male, 25.6 ± 10.6 % for female, P < 0.001). The 260 families showed statistically significant familial tendencies of TS values (P < 0.001). The mean TS of offspring in parental group 1.0, 1.5, 2.0, and 2.5 showed a lower value than that in higher group 3.0, 3.5, and 4.0. In contrast, there were no significant differences in age, daily dietary iron intake, and AST or ALT value among seven groups.

Conclusions

These findings suggest unidentified genetic variations on high TS in Koreans beyond the p.Cys282Tyr and p.His63Asp mutations commonly identified in Caucasians.
Literature
1.
go back to reference Nadakkavukaran IM, Gan EK, Olynyk JK. Screening for hereditary haemochromatosis. Pathology. 2012;44:148–152.CrossRefPubMed Nadakkavukaran IM, Gan EK, Olynyk JK. Screening for hereditary haemochromatosis. Pathology. 2012;44:148–152.CrossRefPubMed
2.
go back to reference El-Serag HB, Inadomi JM, Kowdley KV. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med. 2000;132:261–269.CrossRefPubMed El-Serag HB, Inadomi JM, Kowdley KV. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med. 2000;132:261–269.CrossRefPubMed
3.
go back to reference Powell LW. Chapter 357. Hemochromatosis. In: Longo DL, Fauci AS, Kasper DL, et al., eds. Harrison’s Principles of Internal Medicine, 18e. New York: McGraw-Hill; 2012. Powell LW. Chapter 357. Hemochromatosis. In: Longo DL, Fauci AS, Kasper DL, et al., eds. Harrison’s Principles of Internal Medicine, 18e. New York: McGraw-Hill; 2012.
4.
go back to reference Phatak PD, Bonkovsky HL, Kowdley KV. Hereditary hemochromatosis: time for targeted screening. Ann Intern Med. 2008;149:270–272.CrossRefPubMed Phatak PD, Bonkovsky HL, Kowdley KV. Hereditary hemochromatosis: time for targeted screening. Ann Intern Med. 2008;149:270–272.CrossRefPubMed
5.
go back to reference Pietrangelo A. Hereditary hemochromatosis—a new look at an old disease. N Engl J Med. 2004;350:2383–2397.CrossRefPubMed Pietrangelo A. Hereditary hemochromatosis—a new look at an old disease. N Engl J Med. 2004;350:2383–2397.CrossRefPubMed
6.
go back to reference Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769–1778.CrossRefPubMed Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769–1778.CrossRefPubMed
7.
go back to reference Choi SJ, Min WK, Chun S, et al. Frequencies of C282Y and H63D mutations and transferrin saturation indices in the Korean population. Clin Chem Lab Med. 2002;40:689–692.CrossRefPubMed Choi SJ, Min WK, Chun S, et al. Frequencies of C282Y and H63D mutations and transferrin saturation indices in the Korean population. Clin Chem Lab Med. 2002;40:689–692.CrossRefPubMed
8.
go back to reference Lee SH, Kim JW, Shin SH, et al. HFE gene mutations, serum ferritin level, transferrin saturation, and their clinical correlates in a Korean population. Dig Dis Sci. 2009;54:879–886.CrossRefPubMed Lee SH, Kim JW, Shin SH, et al. HFE gene mutations, serum ferritin level, transferrin saturation, and their clinical correlates in a Korean population. Dig Dis Sci. 2009;54:879–886.CrossRefPubMed
9.
go back to reference Harris EL, McLaren CE, Reboussin DM, et al. Serum ferritin and transferrin saturation in Asians and Pacific Islanders. Arch Intern Med. 2007;167:722–726.CrossRefPubMed Harris EL, McLaren CE, Reboussin DM, et al. Serum ferritin and transferrin saturation in Asians and Pacific Islanders. Arch Intern Med. 2007;167:722–726.CrossRefPubMed
10.
go back to reference Jackson HA, Carter K, Darke C, et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol. 2001;114:474–484.CrossRefPubMed Jackson HA, Carter K, Darke C, et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol. 2001;114:474–484.CrossRefPubMed
11.
go back to reference McPherson R, Pincus M. Chapter 3. Preanalysis. In: Sanford K, McPherson R, eds. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. Philadelphia: Elsevier; 2001. McPherson R, Pincus M. Chapter 3. Preanalysis. In: Sanford K, McPherson R, eds. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. Philadelphia: Elsevier; 2001.
12.
go back to reference Korean Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. The Korea National Health and Nutrition Examination Survey 2010 (KNHANES V-1). https://knhanes.cdc.go.kr. Accessed 20 June 2014. Korean Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. The Korea National Health and Nutrition Examination Survey 2010 (KNHANES V-1). https://​knhanes.​cdc.​go.​kr. Accessed 20 June 2014.
13.
go back to reference Pedersen P, Milman N. Extrinsic factors modifying expressivity of the HFE variant C282Y, H63D, S65C phenotypes in 1,294 Danish men. Ann Hematol. 2009;88:957–965.CrossRefPubMed Pedersen P, Milman N. Extrinsic factors modifying expressivity of the HFE variant C282Y, H63D, S65C phenotypes in 1,294 Danish men. Ann Hematol. 2009;88:957–965.CrossRefPubMed
14.
go back to reference Bothwell TH, Seftel H, Jacobs P, et al. Iron overload in bantu subjects; studies on the availability of iron in bantu beer. Am J Clin Nutr.. 1964;14:47–51.PubMed Bothwell TH, Seftel H, Jacobs P, et al. Iron overload in bantu subjects; studies on the availability of iron in bantu beer. Am J Clin Nutr.. 1964;14:47–51.PubMed
15.
go back to reference Hayashi H, Wakusawa S, Motonishi S, et al. Genetic background of primary iron overload syndromes in Japan. Intern Med. 2006;45:1107–1111.CrossRefPubMed Hayashi H, Wakusawa S, Motonishi S, et al. Genetic background of primary iron overload syndromes in Japan. Intern Med. 2006;45:1107–1111.CrossRefPubMed
16.
go back to reference Lok CY, Merryweather-Clarke AT, Viprakasit V, et al. Iron overload in the Asian community. Blood. 2009;114:20–25.CrossRefPubMed Lok CY, Merryweather-Clarke AT, Viprakasit V, et al. Iron overload in the Asian community. Blood. 2009;114:20–25.CrossRefPubMed
17.
go back to reference Santos PC, Cançado RD, Pereira AC, et al. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients. Blood Cells Mol Dis. 2011;15:302–307.CrossRef Santos PC, Cançado RD, Pereira AC, et al. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients. Blood Cells Mol Dis. 2011;15:302–307.CrossRef
18.
go back to reference Santos PC, Cançado RD, Terada CT, et al. HFE gene mutations and iron status of Brazilian blood donors. Braz J Med Biol Res. 2010;43:107–114.CrossRefPubMed Santos PC, Cançado RD, Terada CT, et al. HFE gene mutations and iron status of Brazilian blood donors. Braz J Med Biol Res. 2010;43:107–114.CrossRefPubMed
Metadata
Title
Analysis of Familial Tendencies in Transferrin Saturation in a Korean Population
Authors
Sung-Hee Oh
Tae-Dong Jeong
Woochang Lee
Sail Chun
Won-Ki Min
Publication date
01-10-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3720-y

Other articles of this Issue 10/2015

Digestive Diseases and Sciences 10/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.